Hybio Pharmaceutical has a total of 774 patents globally, out of which 482 have been granted. Of these 774 patents, more than 38% patents are active. China is where Hybio Pharmaceutical has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, China seems to be the main focused R&D centre and also is the origin country of Hybio Pharmaceutical.
Hybio Pharmaceutical was founded in 1998. The company is specializing in the research, development, manufacturing, and sale of a wide range of peptide products. Its offerings include peptide finished dosage forms, peptide active pharmaceutical ingredients (API), as well as contract research and contract manufacturing services for peptides.
Do read about some of the most popular patents of Hybio Pharmaceutical which have been covered by us in this article and also you can find Hybio Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hybio Pharmaceutical patent portfolio.
How many patents does Hybio Pharmaceutical have?
Hybio Pharmaceutical has a total of 774 patents globally. These patents belong to 563 unique patent families. Out of 774 patents, 299 patents are active.
How Many Patents did Hybio Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Hybio Pharmaceutical Applications Filed | Hybio Pharmaceutical Patents Granted |
| 2024 | 2 | 22 |
| 2023 | 10 | 22 |
| 2022 | 18 | 20 |
| 2021 | 16 | 40 |
| 2020 | 33 | 56 |
| 2019 | 71 | 44 |
| 2018 | 69 | 37 |
| 2017 | 38 | 30 |
| 2016 | 63 | 49 |
| 2015 | 104 | 28 |
| 2014 | 65 | 40 |
How many Hybio Pharmaceutical patents are Alive/Dead?
Worldwide Patents
How Many Patents did Hybio Pharmaceutical File in Different Countries?
Countries in which Hybio Pharmaceutical Filed Patents
| Country | Patents |
| China | 559 |
| Europe (EPO) | 21 |
| United States of America | 16 |
| Germany | 13 |
| Austria | 12 |
| India | 12 |
| Spain | 6 |
| Japan | 5 |
| Indonesia | 4 |
| Denmark | 3 |
| Hungary | 2 |
| Russia | 2 |
| Poland | 2 |
| Eurasian Patent Organization | 1 |
| Malta | 1 |
| South Africa | 1 |
| Lithuania | 1 |
| Portugal | 1 |
| Norway | 1 |
Where are Research Centers of Hybio Pharmaceutical Patents Located?
10 Best Hybio Pharmaceutical Patents
CN106928343A is the most popular patent in the Hybio Pharmaceutical portfolio. It has received 62 citations so far from companies like Shenzhen Jianyuan Pharmaceutical Technology, Yangtze River Pharmaceutical Group Sichuan Hairong Pharmaceutical, and Runhui Biotechnology.
Below is the list of 10 most cited patents of Hybio Pharmaceutical:
| Publication Number | Citation Count |
| CN106928343A | 62 |
| CN102731643A | 36 |
| CN102584945A | 30 |
| CN103467595A | 25 |
| CN104211777A | 22 |
| CN101555272B | 22 |
| CN105504012A | 21 |
| CN102068685A | 20 |
| CN102100906A | 20 |
| CN105753964A | 19 |
What are Hybio Pharmaceutical’s key innovation segments?
What Technologies Are Covered by Hybio Pharmaceutical?
The chart below distributes patents filed by Hybio Pharmaceutical in different countries on the basis of the technology protected in patents. It also represents the markets where Hybio Pharmaceutica thinks it’s important to protect particular technology inventions.
R&D Focus: How has Hybio Pharmaceutical’s search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Hybio Pharmaceutical?